These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13867266)

  • 21. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 22. The toxic effects of citrated blood and the search for a suitable substitute for use in cardiac surgery.
    COOKSON BA; COSTAS-DURIEUX J; BAILEY CP
    Ann Surg; 1954 Apr; 139(4):430-8. PubMed ID: 13149094
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental study on modified fluid gelatin as a serum volume expander].
    Murakami S; Hamabe N; Kitani M; Ota Y; Tanigawa H
    Masui; 1969 Jun; 18(6):500-9. PubMed ID: 5816994
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal function in baboon kidneys during hypotensive, isolated, bloodless perfusion with oxygen or helium gas. Responses to a gelatine plasma substitute.
    Murphy GP; Groenewald JH; Schoonees R; Retief CP; van Zyl JJ; de Klerk JN
    Invest Urol; 1969 Jan; 6(4):348-55. PubMed ID: 4975261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Study of effects of 4 replacement solutions with a fluid gelatin base on platelet aggregation].
    Marcel GA; Sabatier C; Galbrun M; Caspar C
    Nouv Presse Med; 1974 Oct; 3(35):2260. PubMed ID: 4459835
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic and diuretic effects of ECF-replacer with a low concentration of colloid--lactate Ringer solution with 2 percent purified gelatin compared with lactate Ringer modified with gelatin].
    Goto Y; Saito F; Goto T; Kimura H; Aochi O
    Masui; 1974 Feb; 23(2):115-23. PubMed ID: 4858993
    [No Abstract]   [Full Text] [Related]  

  • 27. [Redistribution of fluids in the body of dogs following plethoric injections of polyglucin, gelatinol and plasma].
    Korolev VM
    Patol Fiziol Eksp Ter; 1975; (4):78-80. PubMed ID: 1187232
    [No Abstract]   [Full Text] [Related]  

  • 28. [PRELIMINARY RESULTS OF THE CLINICAL USE OF A NEW PLASMA SUBSTITUTE].
    GUERRINI O; SERIO G
    Minerva Anestesiol; 1963 Sep; 29():377-8. PubMed ID: 14093114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacodynamics of plasma substitutes].
    Mas Marfany J
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):108-14. PubMed ID: 5552978
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modified fluid gelatins and platelet aggregation in vivo in man].
    Migne J; Saint-Maurice JP; Santonja R; Kunz S
    Anesth Analg (Paris); 1976; 3(4):577-84. PubMed ID: 1015644
    [No Abstract]   [Full Text] [Related]  

  • 31. [A plasma-expander with a gelatine base and its effect on blood coagulation, fibrinolysis and function of thrombocytes].
    Fischer M
    Arzneimittelforschung; 1967 Sep; 17(9):1129-31. PubMed ID: 5632285
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on the cardiovascular effect of a 3.5 percent gelatin solution for infusion].
    Retzke U; Schwarz R
    Z Exp Chir; 1973; 6(4):227-36. PubMed ID: 4772913
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxypolygelatin as a plasma substitute.
    CHEN JS; CHEN ML; LIN SS; CHANG AS
    U S Armed Forces Med J; 1952 Oct; 3(10):1479-89. PubMed ID: 12995528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunological research on animals and humans treated with a new plasma substitute drawn from decomposed gelatin. I. General considerations and immunological study in animals].
    BEDARIDA G; MOREO GC
    Riv Emoter Immunoematol; 1962; 9():265-79. PubMed ID: 13970193
    [No Abstract]   [Full Text] [Related]  

  • 35. [Functional and histological studies of the effect of a modified high molecular weight gelatin preparation on the kidneys].
    Hölscher B
    Chirurg; 1968 May; 39(5):228-30. PubMed ID: 5715439
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of Gelafusal infusion on renal function].
    Rusiniak L; Sitarska E; Zienkiewicz K; Scharf R; Kostrzewska E; Kluciński W; Sokołowska K; Gregor A
    Pol Tyg Lek; 1978 Aug; 33(32):1245-7. PubMed ID: 704420
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanism of the action of hemodynamic and complex blood substitutes].
    Rozenberg GIa
    Probl Gematol Pereliv Krovi; 1977 Oct; 22(10):40-6. PubMed ID: 605110
    [No Abstract]   [Full Text] [Related]  

  • 38. [The behavior of various thrombocyte functions in the presence of different plasma substitutes].
    Fischer M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):485-90. PubMed ID: 4193165
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphological findings following single or multiple administration of gelatin plasma substitutes.
    Kief H
    Bibl Haematol; 1969; 33():367-79. PubMed ID: 5384006
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative histologic investigations on the effect of repeated intravenous injections of large quantities of isogenous blood plasma and Physiogel in mice].
    Cottier H
    Helv Chir Acta; 1966 May; 33(3):376-82. PubMed ID: 5994657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.